Michael Gray Biography and Net Worth

Chief Financial Officer and Chief Operating Officer of Upstream Bio

As Chief Financial Officer and Chief Operating Officer of Upstream Bio, Mike Gray, MBA, leads all facets of Upstream’s financial strategy and daily operations. He has more than 25 years of public-private leadership experience and was most recently the CFO and COO of Carmot Therapeutics, where he helped to secure the company’s acquisition by Roche in 2024. Before this, he was CFO and COO of Imara and Arsanis, working with the leadership teams of each company in completing initial public offerings and building leading organizations. Mr. Gray previously held a number of leadership positions at Curis. Mike served on the Board of Directors of Therapeutics Acquisition Corporation, a special purpose acquisition corporation, through its merger with POINT Biopharma, which was subsequently acquired by Eli Lilly and Company in March 2024. He received his BS in business administration (accounting) from Bryant College and an MBA in corporate finance and entrepreneurial management from the F.W. Olin Graduate School of Business at Babson College.

What is Michael Gray's net worth?: The estimated net worth of Michael Gray is at least $282.84 thousand as of March 16th, 2026. Mr. Gray owns 29,648 shares of Upstream Bio stock worth more than $282,842 as of March 25th. This net worth approximation does not reflect any other investments that Mr. Gray may own. Learn More about Michael Gray's net worth.
How old is Michael Gray?: Mr. Gray is currently 53 years old. There are 2 older executives and no younger executives at Upstream Bio. The oldest executive at Upstream Bio is Mr. Aaron Deykin M.D., Chief Medical Officer & Head of Research and Development, who is 58 years old. Learn More on Michael Gray's age.
How do I contact Michael Gray?: The corporate mailing address for Mr. Gray and other Upstream Bio executives is 890 Winter Street, Suite 200, Waltham, MA 02451, United States. Upstream Bio can also be reached via phone at (781) 208-2466 and via email at [email protected]. Learn More on Michael Gray's contact information.
Has Michael Gray been buying or selling shares of Upstream Bio?: During the last ninety days, Michael Gray has sold $7,915.08 in shares of Upstream Bio stock. Most recently, Michael Gray sold 852 shares of the business's stock in a transaction on Monday, March 16th. The shares were sold at an average price of $9.29, for a transaction totalling $7,915.08. Following the completion of the sale, the chief financial officer now directly owns 29,648 shares of the company's stock, valued at $275,429.92. Learn More on Michael Gray's trading history.
Who are Upstream Bio's active insiders?: Upstream Bio's insider roster includes Erez Chimovits (Director), and Michael Gray (Chief Financial Officer and Chief Operating Officer). Learn More on Upstream Bio's active insiders.
Are insiders buying or selling shares of Upstream Bio?: During the last twelve months, insiders at the sold shares 1 times. They sold a total of 852 shares worth more than $7,915.08. The most recent insider tranaction occured on March, 16th when CFO Michael Gray sold 852 shares worth more than $7,915.08. Insiders at Upstream Bio own 13.6% of the company. Learn More about insider trades at Upstream Bio.
Information on this page was last updated on 3/16/2026.

Michael Gray Insider Trading History at Upstream Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
3/16/2026	Sell	852	$9.29	$7,915.08	29,648

Michael Gray Buying and Selling Activity at Upstream Bio

Upstream Bio Company Overview

Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.

Today's Range

Now: $9.47

$8.67

$9.57

50 Day Range

MA: $17.26

$7.36

$32.50

2 Week Range

Now: $9.47

$5.14

$33.68

Volume

413,013 shs

Average Volume

1,343,504 shs

Market Capitalization

$511.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.96

Michael Gray Biography and Net Worth

What is Michael Gray's net worth?

How old is Michael Gray?

How do I contact Michael Gray?

Has Michael Gray been buying or selling shares of Upstream Bio?

Who are Upstream Bio's active insiders?

Are insiders buying or selling shares of Upstream Bio?